Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2023 | Story Kate Poen | Photo Supplied
Kate Poen
Kate Poen is an Academic Adviser in the Centre for Teaching and Learning.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Kate Poen, Academic Adviser in the Centre for Teaching and Learning, shares her UFS journey:

 

Q: Year of graduation from the UFS:

A: April 2018 and 2023.

Q: Qualification obtained from the UFS:

A: BSocSci Honours in Psychology and PGDip in Higher Education.

Q: Date of joining the UFS as a staff member:

A: I joined the UFS as a staff member in 2017.

Q: Initial job title and current job title:

A: My initial job was as a Teaching Assistant for UFS101 (now UFSS) under Transition Development and Success (TDS) and I am currently an Academic Adviser under Advising, Access, and Success (AAS) in the Centre for Teaching and Learning.

Q: How did the UFS prepare you for the professional world?

A: The UFS has taught me responsibility and accountability as a professional. It instilled in me the competence of lifelong learning, to consistently develop myself personally and professionally, as well as the ability to always innovate my skills, and not only be an individual able to compete on a national level, but globally in the higher education space as well.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: Transitioning from a UFS alumnus to a staff member has been interesting. Being a UFS alumnus in my experience opens the door to opportunities for growth and development, even with the challenges it does bring. It is a personal choice as to whether one sees and uses the opportunities. What it does provide one with is definitely an informed perspective of the staff experiences, especially support staff.

Q: Any additional comments about your experience?

A: I am grateful for the opportunities I’ve been afforded at the institution to not only grow as an individual, but also to make a difference and a little impact in the work that I do daily. Grateful for the relationships I was also able to establish with colleagues in different spaces on all three of our campuses.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept